Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Peripheral Arterial Disease (PAD) Therapeutics market report explains the definition, types, applications, major countries, and major players of the Peripheral Arterial Disease (PAD) Therapeutics market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
AstraZeneca Plc (UK)
TheraVasc Inc (US)
Multi Gene Vascular Systems Ltd (Israel)
Bayer HealthCare Pharmaceuticals (Germany)
Athersys Inc (US)
Merck & Co Inc (US)
Betagenon AB (Sweden)
ViroMed Co Ltd (Korea)
Proteon Therapeutics Inc (US)
Symic Bio Inc (US)
Sanofi SA (France)
Bristol-Myers Squibb Company (US)
AnGes MG Inc (Japan)
miRagen Therapeutics Inc (US)
By Type:
Anti-Platelet Drugs
Dual Antiplatelet Therapy Drugs
Others
By End-User:
Hospitals
Clinics
Others
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Peripheral Arterial Disease (PAD) Therapeutics Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Peripheral Arterial Disease (PAD) Therapeutics Outlook to 2028- Original Forecasts
-
2.2 Peripheral Arterial Disease (PAD) Therapeutics Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Peripheral Arterial Disease (PAD) Therapeutics Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Peripheral Arterial Disease (PAD) Therapeutics Market- Recent Developments
-
6.1 Peripheral Arterial Disease (PAD) Therapeutics Market News and Developments
-
6.2 Peripheral Arterial Disease (PAD) Therapeutics Market Deals Landscape
7 Peripheral Arterial Disease (PAD) Therapeutics Raw Materials and Cost Structure Analysis
-
7.1 Peripheral Arterial Disease (PAD) Therapeutics Key Raw Materials
-
7.2 Peripheral Arterial Disease (PAD) Therapeutics Price Trend of Key Raw Materials
-
7.3 Peripheral Arterial Disease (PAD) Therapeutics Key Suppliers of Raw Materials
-
7.4 Peripheral Arterial Disease (PAD) Therapeutics Market Concentration Rate of Raw Materials
-
7.5 Peripheral Arterial Disease (PAD) Therapeutics Cost Structure Analysis
-
7.5.1 Peripheral Arterial Disease (PAD) Therapeutics Raw Materials Analysis
-
7.5.2 Peripheral Arterial Disease (PAD) Therapeutics Labor Cost Analysis
-
7.5.3 Peripheral Arterial Disease (PAD) Therapeutics Manufacturing Expenses Analysis
8 Global Peripheral Arterial Disease (PAD) Therapeutics Import and Export Analysis (Top 10 Countries)
-
8.1 Global Peripheral Arterial Disease (PAD) Therapeutics Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Peripheral Arterial Disease (PAD) Therapeutics Export by Region (Top 10 Countries) (2017-2028)
9 Global Peripheral Arterial Disease (PAD) Therapeutics Market Outlook by Types and Applications to 2022
-
9.1 Global Peripheral Arterial Disease (PAD) Therapeutics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Anti-Platelet Drugs Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Dual Antiplatelet Therapy Drugs Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Peripheral Arterial Disease (PAD) Therapeutics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Peripheral Arterial Disease (PAD) Therapeutics Market Analysis and Outlook till 2022
-
10.1 Global Peripheral Arterial Disease (PAD) Therapeutics Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Peripheral Arterial Disease (PAD) Therapeutics Consumption (2017-2022)
-
10.2.2 Canada Peripheral Arterial Disease (PAD) Therapeutics Consumption (2017-2022)
-
10.2.3 Mexico Peripheral Arterial Disease (PAD) Therapeutics Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Peripheral Arterial Disease (PAD) Therapeutics Consumption (2017-2022)
-
10.3.2 UK Peripheral Arterial Disease (PAD) Therapeutics Consumption (2017-2022)
-
10.3.3 Spain Peripheral Arterial Disease (PAD) Therapeutics Consumption (2017-2022)
-
10.3.4 Belgium Peripheral Arterial Disease (PAD) Therapeutics Consumption (2017-2022)
-
10.3.5 France Peripheral Arterial Disease (PAD) Therapeutics Consumption (2017-2022)
-
10.3.6 Italy Peripheral Arterial Disease (PAD) Therapeutics Consumption (2017-2022)
-
10.3.7 Denmark Peripheral Arterial Disease (PAD) Therapeutics Consumption (2017-2022)
-
10.3.8 Finland Peripheral Arterial Disease (PAD) Therapeutics Consumption (2017-2022)
-
10.3.9 Norway Peripheral Arterial Disease (PAD) Therapeutics Consumption (2017-2022)
-
10.3.10 Sweden Peripheral Arterial Disease (PAD) Therapeutics Consumption (2017-2022)
-
10.3.11 Poland Peripheral Arterial Disease (PAD) Therapeutics Consumption (2017-2022)
-
10.3.12 Russia Peripheral Arterial Disease (PAD) Therapeutics Consumption (2017-2022)
-
10.3.13 Turkey Peripheral Arterial Disease (PAD) Therapeutics Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Peripheral Arterial Disease (PAD) Therapeutics Consumption (2017-2022)
-
10.4.2 Japan Peripheral Arterial Disease (PAD) Therapeutics Consumption (2017-2022)
-
10.4.3 India Peripheral Arterial Disease (PAD) Therapeutics Consumption (2017-2022)
-
10.4.4 South Korea Peripheral Arterial Disease (PAD) Therapeutics Consumption (2017-2022)
-
10.4.5 Pakistan Peripheral Arterial Disease (PAD) Therapeutics Consumption (2017-2022)
-
10.4.6 Bangladesh Peripheral Arterial Disease (PAD) Therapeutics Consumption (2017-2022)
-
10.4.7 Indonesia Peripheral Arterial Disease (PAD) Therapeutics Consumption (2017-2022)
-
10.4.8 Thailand Peripheral Arterial Disease (PAD) Therapeutics Consumption (2017-2022)
-
10.4.9 Singapore Peripheral Arterial Disease (PAD) Therapeutics Consumption (2017-2022)
-
10.4.10 Malaysia Peripheral Arterial Disease (PAD) Therapeutics Consumption (2017-2022)
-
10.4.11 Philippines Peripheral Arterial Disease (PAD) Therapeutics Consumption (2017-2022)
-
10.4.12 Vietnam Peripheral Arterial Disease (PAD) Therapeutics Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Peripheral Arterial Disease (PAD) Therapeutics Consumption (2017-2022)
-
10.5.2 Colombia Peripheral Arterial Disease (PAD) Therapeutics Consumption (2017-2022)
-
10.5.3 Chile Peripheral Arterial Disease (PAD) Therapeutics Consumption (2017-2022)
-
10.5.4 Argentina Peripheral Arterial Disease (PAD) Therapeutics Consumption (2017-2022)
-
10.5.5 Venezuela Peripheral Arterial Disease (PAD) Therapeutics Consumption (2017-2022)
-
10.5.6 Peru Peripheral Arterial Disease (PAD) Therapeutics Consumption (2017-2022)
-
10.5.7 Puerto Rico Peripheral Arterial Disease (PAD) Therapeutics Consumption (2017-2022)
-
10.5.8 Ecuador Peripheral Arterial Disease (PAD) Therapeutics Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Peripheral Arterial Disease (PAD) Therapeutics Consumption (2017-2022)
-
10.6.2 Kuwait Peripheral Arterial Disease (PAD) Therapeutics Consumption (2017-2022)
-
10.6.3 Oman Peripheral Arterial Disease (PAD) Therapeutics Consumption (2017-2022)
-
10.6.4 Qatar Peripheral Arterial Disease (PAD) Therapeutics Consumption (2017-2022)
-
10.6.5 Saudi Arabia Peripheral Arterial Disease (PAD) Therapeutics Consumption (2017-2022)
-
10.6.6 United Arab Emirates Peripheral Arterial Disease (PAD) Therapeutics Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Peripheral Arterial Disease (PAD) Therapeutics Consumption (2017-2022)
-
10.7.2 South Africa Peripheral Arterial Disease (PAD) Therapeutics Consumption (2017-2022)
-
10.7.3 Egypt Peripheral Arterial Disease (PAD) Therapeutics Consumption (2017-2022)
-
10.7.4 Algeria Peripheral Arterial Disease (PAD) Therapeutics Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Peripheral Arterial Disease (PAD) Therapeutics Consumption (2017-2022)
-
10.8.2 New Zealand Peripheral Arterial Disease (PAD) Therapeutics Consumption (2017-2022)
11 Global Peripheral Arterial Disease (PAD) Therapeutics Competitive Analysis
-
11.1 AstraZeneca Plc (UK)
-
11.1.1 AstraZeneca Plc (UK) Company Details
-
11.1.2 AstraZeneca Plc (UK) Peripheral Arterial Disease (PAD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 AstraZeneca Plc (UK) Peripheral Arterial Disease (PAD) Therapeutics Main Business and Markets Served
-
11.1.4 AstraZeneca Plc (UK) Peripheral Arterial Disease (PAD) Therapeutics Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 TheraVasc Inc (US)
-
11.2.1 TheraVasc Inc (US) Company Details
-
11.2.2 TheraVasc Inc (US) Peripheral Arterial Disease (PAD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 TheraVasc Inc (US) Peripheral Arterial Disease (PAD) Therapeutics Main Business and Markets Served
-
11.2.4 TheraVasc Inc (US) Peripheral Arterial Disease (PAD) Therapeutics Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Multi Gene Vascular Systems Ltd (Israel)
-
11.3.1 Multi Gene Vascular Systems Ltd (Israel) Company Details
-
11.3.2 Multi Gene Vascular Systems Ltd (Israel) Peripheral Arterial Disease (PAD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Multi Gene Vascular Systems Ltd (Israel) Peripheral Arterial Disease (PAD) Therapeutics Main Business and Markets Served
-
11.3.4 Multi Gene Vascular Systems Ltd (Israel) Peripheral Arterial Disease (PAD) Therapeutics Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Bayer HealthCare Pharmaceuticals (Germany)
-
11.4.1 Bayer HealthCare Pharmaceuticals (Germany) Company Details
-
11.4.2 Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Therapeutics Main Business and Markets Served
-
11.4.4 Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Therapeutics Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Athersys Inc (US)
-
11.5.1 Athersys Inc (US) Company Details
-
11.5.2 Athersys Inc (US) Peripheral Arterial Disease (PAD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Athersys Inc (US) Peripheral Arterial Disease (PAD) Therapeutics Main Business and Markets Served
-
11.5.4 Athersys Inc (US) Peripheral Arterial Disease (PAD) Therapeutics Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Merck & Co Inc (US)
-
11.6.1 Merck & Co Inc (US) Company Details
-
11.6.2 Merck & Co Inc (US) Peripheral Arterial Disease (PAD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Merck & Co Inc (US) Peripheral Arterial Disease (PAD) Therapeutics Main Business and Markets Served
-
11.6.4 Merck & Co Inc (US) Peripheral Arterial Disease (PAD) Therapeutics Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Betagenon AB (Sweden)
-
11.7.1 Betagenon AB (Sweden) Company Details
-
11.7.2 Betagenon AB (Sweden) Peripheral Arterial Disease (PAD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Betagenon AB (Sweden) Peripheral Arterial Disease (PAD) Therapeutics Main Business and Markets Served
-
11.7.4 Betagenon AB (Sweden) Peripheral Arterial Disease (PAD) Therapeutics Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 ViroMed Co Ltd (Korea)
-
11.8.1 ViroMed Co Ltd (Korea) Company Details
-
11.8.2 ViroMed Co Ltd (Korea) Peripheral Arterial Disease (PAD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 ViroMed Co Ltd (Korea) Peripheral Arterial Disease (PAD) Therapeutics Main Business and Markets Served
-
11.8.4 ViroMed Co Ltd (Korea) Peripheral Arterial Disease (PAD) Therapeutics Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Proteon Therapeutics Inc (US)
-
11.9.1 Proteon Therapeutics Inc (US) Company Details
-
11.9.2 Proteon Therapeutics Inc (US) Peripheral Arterial Disease (PAD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Proteon Therapeutics Inc (US) Peripheral Arterial Disease (PAD) Therapeutics Main Business and Markets Served
-
11.9.4 Proteon Therapeutics Inc (US) Peripheral Arterial Disease (PAD) Therapeutics Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Symic Bio Inc (US)
-
11.10.1 Symic Bio Inc (US) Company Details
-
11.10.2 Symic Bio Inc (US) Peripheral Arterial Disease (PAD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Symic Bio Inc (US) Peripheral Arterial Disease (PAD) Therapeutics Main Business and Markets Served
-
11.10.4 Symic Bio Inc (US) Peripheral Arterial Disease (PAD) Therapeutics Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Sanofi SA (France)
-
11.11.1 Sanofi SA (France) Company Details
-
11.11.2 Sanofi SA (France) Peripheral Arterial Disease (PAD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Sanofi SA (France) Peripheral Arterial Disease (PAD) Therapeutics Main Business and Markets Served
-
11.11.4 Sanofi SA (France) Peripheral Arterial Disease (PAD) Therapeutics Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 Bristol-Myers Squibb Company (US)
-
11.12.1 Bristol-Myers Squibb Company (US) Company Details
-
11.12.2 Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Therapeutics Main Business and Markets Served
-
11.12.4 Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Therapeutics Product Portfolio
-
11.12.5 Recent Research and Development Strategies
-
11.13 AnGes MG Inc (Japan)
-
11.13.1 AnGes MG Inc (Japan) Company Details
-
11.13.2 AnGes MG Inc (Japan) Peripheral Arterial Disease (PAD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
11.13.3 AnGes MG Inc (Japan) Peripheral Arterial Disease (PAD) Therapeutics Main Business and Markets Served
-
11.13.4 AnGes MG Inc (Japan) Peripheral Arterial Disease (PAD) Therapeutics Product Portfolio
-
11.13.5 Recent Research and Development Strategies
-
11.14 miRagen Therapeutics Inc (US)
-
11.14.1 miRagen Therapeutics Inc (US) Company Details
-
11.14.2 miRagen Therapeutics Inc (US) Peripheral Arterial Disease (PAD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
11.14.3 miRagen Therapeutics Inc (US) Peripheral Arterial Disease (PAD) Therapeutics Main Business and Markets Served
-
11.14.4 miRagen Therapeutics Inc (US) Peripheral Arterial Disease (PAD) Therapeutics Product Portfolio
-
11.14.5 Recent Research and Development Strategies
12 Global Peripheral Arterial Disease (PAD) Therapeutics Market Outlook by Types and Applications to 2028
-
12.1 Global Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Anti-Platelet Drugs Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Dual Antiplatelet Therapy Drugs Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Peripheral Arterial Disease (PAD) Therapeutics Market Analysis and Outlook to 2028
-
13.1 Global Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast (2022-2028)
-
13.2.2 Canada Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast (2022-2028)
-
13.2.3 Mexico Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast (2022-2028)
-
13.3.2 UK Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast (2022-2028)
-
13.3.3 Spain Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast (2022-2028)
-
13.3.4 Belgium Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast (2022-2028)
-
13.3.5 France Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast (2022-2028)
-
13.3.6 Italy Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast (2022-2028)
-
13.3.7 Denmark Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast (2022-2028)
-
13.3.8 Finland Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast (2022-2028)
-
13.3.9 Norway Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast (2022-2028)
-
13.3.10 Sweden Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast (2022-2028)
-
13.3.11 Poland Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast (2022-2028)
-
13.3.12 Russia Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast (2022-2028)
-
13.3.13 Turkey Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast (2022-2028)
-
13.4.2 Japan Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast (2022-2028)
-
13.4.3 India Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast (2022-2028)
-
13.4.4 South Korea Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast (2022-2028)
-
13.4.8 Thailand Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast (2022-2028)
-
13.4.9 Singapore Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast (2022-2028)
-
13.4.11 Philippines Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast (2022-2028)
-
13.5.2 Colombia Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast (2022-2028)
-
13.5.3 Chile Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast (2022-2028)
-
13.5.4 Argentina Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast (2022-2028)
-
13.5.6 Peru Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast (2022-2028)
-
13.6.3 Oman Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast (2022-2028)
-
13.6.4 Qatar Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast (2022-2028)
-
13.7.2 South Africa Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast (2022-2028)
-
13.7.3 Egypt Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast (2022-2028)
-
13.7.4 Algeria Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Peripheral Arterial Disease (PAD) Therapeutics
-
Figure of Peripheral Arterial Disease (PAD) Therapeutics Picture
-
Table Global Peripheral Arterial Disease (PAD) Therapeutics Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Peripheral Arterial Disease (PAD) Therapeutics Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Anti-Platelet Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Dual Antiplatelet Therapy Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Peripheral Arterial Disease (PAD) Therapeutics Consumption by Country (2017-2022)
-
Table North America Peripheral Arterial Disease (PAD) Therapeutics Consumption by Country (2017-2022)
-
Figure United States Peripheral Arterial Disease (PAD) Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Canada Peripheral Arterial Disease (PAD) Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Mexico Peripheral Arterial Disease (PAD) Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Europe Peripheral Arterial Disease (PAD) Therapeutics Consumption by Country (2017-2022)
-
Figure Germany Peripheral Arterial Disease (PAD) Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure UK Peripheral Arterial Disease (PAD) Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Spain Peripheral Arterial Disease (PAD) Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Belgium Peripheral Arterial Disease (PAD) Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure France Peripheral Arterial Disease (PAD) Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Italy Peripheral Arterial Disease (PAD) Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Denmark Peripheral Arterial Disease (PAD) Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Finland Peripheral Arterial Disease (PAD) Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Norway Peripheral Arterial Disease (PAD) Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Sweden Peripheral Arterial Disease (PAD) Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Poland Peripheral Arterial Disease (PAD) Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Russia Peripheral Arterial Disease (PAD) Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Turkey Peripheral Arterial Disease (PAD) Therapeutics Consumption and Growth Rate (2017-2022)
-
Table APAC Peripheral Arterial Disease (PAD) Therapeutics Consumption by Country (2017-2022)
-
Figure China Peripheral Arterial Disease (PAD) Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Japan Peripheral Arterial Disease (PAD) Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure India Peripheral Arterial Disease (PAD) Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Peripheral Arterial Disease (PAD) Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Peripheral Arterial Disease (PAD) Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Peripheral Arterial Disease (PAD) Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Peripheral Arterial Disease (PAD) Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Thailand Peripheral Arterial Disease (PAD) Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Singapore Peripheral Arterial Disease (PAD) Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Peripheral Arterial Disease (PAD) Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Philippines Peripheral Arterial Disease (PAD) Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Peripheral Arterial Disease (PAD) Therapeutics Consumption and Growth Rate (2017-2022)
-
Table South America Peripheral Arterial Disease (PAD) Therapeutics Consumption by Country (2017-2022)
-
Figure Brazil Peripheral Arterial Disease (PAD) Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Colombia Peripheral Arterial Disease (PAD) Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Chile Peripheral Arterial Disease (PAD) Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Argentina Peripheral Arterial Disease (PAD) Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Peripheral Arterial Disease (PAD) Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Peru Peripheral Arterial Disease (PAD) Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Peripheral Arterial Disease (PAD) Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Peripheral Arterial Disease (PAD) Therapeutics Consumption and Growth Rate (2017-2022)
-
Table GCC Peripheral Arterial Disease (PAD) Therapeutics Consumption by Country (2017-2022)
-
Figure Bahrain Peripheral Arterial Disease (PAD) Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Peripheral Arterial Disease (PAD) Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Oman Peripheral Arterial Disease (PAD) Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Qatar Peripheral Arterial Disease (PAD) Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Peripheral Arterial Disease (PAD) Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Peripheral Arterial Disease (PAD) Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Africa Peripheral Arterial Disease (PAD) Therapeutics Consumption by Country (2017-2022)
-
Figure Nigeria Peripheral Arterial Disease (PAD) Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure South Africa Peripheral Arterial Disease (PAD) Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Egypt Peripheral Arterial Disease (PAD) Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Algeria Peripheral Arterial Disease (PAD) Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Oceania Peripheral Arterial Disease (PAD) Therapeutics Consumption by Country (2017-2022)
-
Figure Australia Peripheral Arterial Disease (PAD) Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Peripheral Arterial Disease (PAD) Therapeutics Consumption and Growth Rate (2017-2022)
-
Table AstraZeneca Plc (UK) Company Details
-
Table AstraZeneca Plc (UK) Peripheral Arterial Disease (PAD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Plc (UK) Peripheral Arterial Disease (PAD) Therapeutics Main Business and Markets Served
-
Table AstraZeneca Plc (UK) Peripheral Arterial Disease (PAD) Therapeutics Product Portfolio
-
Table TheraVasc Inc (US) Company Details
-
Table TheraVasc Inc (US) Peripheral Arterial Disease (PAD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table TheraVasc Inc (US) Peripheral Arterial Disease (PAD) Therapeutics Main Business and Markets Served
-
Table TheraVasc Inc (US) Peripheral Arterial Disease (PAD) Therapeutics Product Portfolio
-
Table Multi Gene Vascular Systems Ltd (Israel) Company Details
-
Table Multi Gene Vascular Systems Ltd (Israel) Peripheral Arterial Disease (PAD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Multi Gene Vascular Systems Ltd (Israel) Peripheral Arterial Disease (PAD) Therapeutics Main Business and Markets Served
-
Table Multi Gene Vascular Systems Ltd (Israel) Peripheral Arterial Disease (PAD) Therapeutics Product Portfolio
-
Table Bayer HealthCare Pharmaceuticals (Germany) Company Details
-
Table Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Therapeutics Main Business and Markets Served
-
Table Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Therapeutics Product Portfolio
-
Table Athersys Inc (US) Company Details
-
Table Athersys Inc (US) Peripheral Arterial Disease (PAD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Athersys Inc (US) Peripheral Arterial Disease (PAD) Therapeutics Main Business and Markets Served
-
Table Athersys Inc (US) Peripheral Arterial Disease (PAD) Therapeutics Product Portfolio
-
Table Merck & Co Inc (US) Company Details
-
Table Merck & Co Inc (US) Peripheral Arterial Disease (PAD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck & Co Inc (US) Peripheral Arterial Disease (PAD) Therapeutics Main Business and Markets Served
-
Table Merck & Co Inc (US) Peripheral Arterial Disease (PAD) Therapeutics Product Portfolio
-
Table Betagenon AB (Sweden) Company Details
-
Table Betagenon AB (Sweden) Peripheral Arterial Disease (PAD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Betagenon AB (Sweden) Peripheral Arterial Disease (PAD) Therapeutics Main Business and Markets Served
-
Table Betagenon AB (Sweden) Peripheral Arterial Disease (PAD) Therapeutics Product Portfolio
-
Table ViroMed Co Ltd (Korea) Company Details
-
Table ViroMed Co Ltd (Korea) Peripheral Arterial Disease (PAD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table ViroMed Co Ltd (Korea) Peripheral Arterial Disease (PAD) Therapeutics Main Business and Markets Served
-
Table ViroMed Co Ltd (Korea) Peripheral Arterial Disease (PAD) Therapeutics Product Portfolio
-
Table Proteon Therapeutics Inc (US) Company Details
-
Table Proteon Therapeutics Inc (US) Peripheral Arterial Disease (PAD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Proteon Therapeutics Inc (US) Peripheral Arterial Disease (PAD) Therapeutics Main Business and Markets Served
-
Table Proteon Therapeutics Inc (US) Peripheral Arterial Disease (PAD) Therapeutics Product Portfolio
-
Table Symic Bio Inc (US) Company Details
-
Table Symic Bio Inc (US) Peripheral Arterial Disease (PAD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Symic Bio Inc (US) Peripheral Arterial Disease (PAD) Therapeutics Main Business and Markets Served
-
Table Symic Bio Inc (US) Peripheral Arterial Disease (PAD) Therapeutics Product Portfolio
-
Table Sanofi SA (France) Company Details
-
Table Sanofi SA (France) Peripheral Arterial Disease (PAD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi SA (France) Peripheral Arterial Disease (PAD) Therapeutics Main Business and Markets Served
-
Table Sanofi SA (France) Peripheral Arterial Disease (PAD) Therapeutics Product Portfolio
-
Table Bristol-Myers Squibb Company (US) Company Details
-
Table Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Therapeutics Main Business and Markets Served
-
Table Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Therapeutics Product Portfolio
-
Table AnGes MG Inc (Japan) Company Details
-
Table AnGes MG Inc (Japan) Peripheral Arterial Disease (PAD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table AnGes MG Inc (Japan) Peripheral Arterial Disease (PAD) Therapeutics Main Business and Markets Served
-
Table AnGes MG Inc (Japan) Peripheral Arterial Disease (PAD) Therapeutics Product Portfolio
-
Table miRagen Therapeutics Inc (US) Company Details
-
Table miRagen Therapeutics Inc (US) Peripheral Arterial Disease (PAD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table miRagen Therapeutics Inc (US) Peripheral Arterial Disease (PAD) Therapeutics Main Business and Markets Served
-
Table miRagen Therapeutics Inc (US) Peripheral Arterial Disease (PAD) Therapeutics Product Portfolio
-
Figure Global Anti-Platelet Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Dual Antiplatelet Therapy Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast by Country (2022-2028)
-
Table North America Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure United States Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure Germany Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure China Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure Brazil Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure Australia Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
